Cargando…
Evaluation of the Clinical Systems for Polymyxin Susceptibility Testing of Clinical Gram-Negative Bacteria in China
OBJECTIVES: The performance of mainstream commercial antimicrobial susceptibility testing systems on polymyxins has not been well evaluated in China. In this study, three antimicrobial susceptibility testing systems were evaluated for polymyxin B and colistin. METHODS: The MICs of 257 Gram-negative...
Autores principales: | Zhu, Ying, Jia, Peiyao, Zhou, Menglan, Zhang, Jingjia, Zhang, Ge, Kang, Wei, Duan, Simeng, Wang, Tong, Xu, Yingchun, Yang, Qiwen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7937900/ https://www.ncbi.nlm.nih.gov/pubmed/33692761 http://dx.doi.org/10.3389/fmicb.2020.610604 |
Ejemplares similares
-
Antimicrobial susceptibility to polymyxin B and other comparators against Gram-negative bacteria isolated from bloodstream infections in China: Results from CARVIS-NET program
por: Xi, Jingyuan, et al.
Publicado: (2022) -
Susceptibilities of Gram-negative bacilli from hospital- and community-acquired intra-abdominal and urinary tract infections: a 2016–2017 update of the Chinese SMART study
por: Zhang, Hui, et al.
Publicado: (2019) -
SuperPolymyxin™ Medium for the Screening of Colistin-Resistant Gram-Negative Bacteria in Stool Samples
por: Przybysz, Sara M., et al.
Publicado: (2018) -
High Prevalence of Extended-Spectrum Beta-Lactamases in Escherichia coli Strains Collected From Strictly Defined Community-Acquired Urinary Tract Infections in Adults in China: A Multicenter Prospective Clinical Microbiological and Molecular Study
por: Jia, Peiyao, et al.
Publicado: (2021) -
Performance Evaluation of BD Phoenix NMIC-413 Antimicrobial Susceptibility Testing Panel for Imipenem, Meropenem, and Ertapenem Against Clinical Carbapenem-Resistant and Carbapenem-Susceptible Enterobacterales
por: Zhang, Jingjia, et al.
Publicado: (2021)